A novel SMAD9 nonsense variant in an 11-year-old Japanese patient with diffuse pulmonary arteriovenous malformation: A case report

Q4 Medicine
Yumiko Asai MD , Kazuyoshi Saito MD, PhD , Keiko Ohta-Ogo MD, PhD , Kinta Hatakeyama MD, PhD , Eiko Sakurai MD, PhD , Hokuto Akamatsu MD, PhD , Daijiro Suzuki MD, PhD , Arisa Kojima MD, PhD , Hidetoshi Uchida MD, PhD , Yoichi Nakajima MD, PhD , Tadayoshi Hata MD, PhD , Yasushi Hoshikawa MD, PhD , Tetsushi Yoshikawa MD, PhD
{"title":"A novel SMAD9 nonsense variant in an 11-year-old Japanese patient with diffuse pulmonary arteriovenous malformation: A case report","authors":"Yumiko Asai MD ,&nbsp;Kazuyoshi Saito MD, PhD ,&nbsp;Keiko Ohta-Ogo MD, PhD ,&nbsp;Kinta Hatakeyama MD, PhD ,&nbsp;Eiko Sakurai MD, PhD ,&nbsp;Hokuto Akamatsu MD, PhD ,&nbsp;Daijiro Suzuki MD, PhD ,&nbsp;Arisa Kojima MD, PhD ,&nbsp;Hidetoshi Uchida MD, PhD ,&nbsp;Yoichi Nakajima MD, PhD ,&nbsp;Tadayoshi Hata MD, PhD ,&nbsp;Yasushi Hoshikawa MD, PhD ,&nbsp;Tetsushi Yoshikawa MD, PhD","doi":"10.1016/j.jccase.2024.11.010","DOIUrl":null,"url":null,"abstract":"<div><div>Most cases of pulmonary arteriovenous malformation (PAVM) are associated with hereditary hemorrhagic telangiectasia (HHT). HHT is typically caused by loss-of-function gene mutations in the genes <em>ENG</em>, <em>ACVRL1</em>, or <em>SMAD4</em>, all participating in transforming growth factor β (TGF-β) family signaling pathways. We describe the case of an 11-year-old Japanese girl with PAVM, with no known family history of HHT or similar disease. She was found to carry a novel nonsense variant in <em>SMAD9</em> (SMAD9-p. T267*), which we speculate contributed to her disease, because <em>SMAD9</em> also participates in TGF-β family signaling pathways. <em>SMAD9</em> mutations have been linked with pulmonary arterial hypertension (PAH), and, hence, mutations in <em>SMAD9</em>—as for <em>ENG</em>, <em>ACVRL1</em>, and <em>SMAD4</em>—may predispose to both PAH and HHT(−characteristic) disease features. The PAVM in our patient spread diffusely inside the lower lobe of the left lung, and coil embolization was considered difficult. Therefore, after feasibility assessment by performing a balloon occlusion test during cardiac catheterization, left lower lobectomy was performed. The patient's dyspnea recovered well postoperatively, and two years later an increase in left lung volume was observed and disease symptoms had not recurred. Thus, if PAVM spreads diffusely in a certain lung area, surgical treatment can be a viable option.</div></div><div><h3>Learning objective</h3><div><em>SMAD9</em> gene mutations have been linked to pulmonary arterial hypertension (PAH). However, their associations with hereditary hemorrhagic telangiectasia (HHT) or pulmonary arteriovenous malformation (PAVM), which usually is HHT-associated, have not been reported previously. Our PAVM patient carrying a <em>SMAD9</em> variant suggests that mutations in this gene, like in others participating in TGF-β family signaling pathways (like <em>ENG</em>, <em>ACVRL1</em>, and <em>SMAD4</em>), predispose to both PAH and HHT(−characteristic) disease features. Diffuse PAVM confined to a lung area may be treated by lobectomy.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 3","pages":"Pages 80-83"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiology Cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878540924001087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Most cases of pulmonary arteriovenous malformation (PAVM) are associated with hereditary hemorrhagic telangiectasia (HHT). HHT is typically caused by loss-of-function gene mutations in the genes ENG, ACVRL1, or SMAD4, all participating in transforming growth factor β (TGF-β) family signaling pathways. We describe the case of an 11-year-old Japanese girl with PAVM, with no known family history of HHT or similar disease. She was found to carry a novel nonsense variant in SMAD9 (SMAD9-p. T267*), which we speculate contributed to her disease, because SMAD9 also participates in TGF-β family signaling pathways. SMAD9 mutations have been linked with pulmonary arterial hypertension (PAH), and, hence, mutations in SMAD9—as for ENG, ACVRL1, and SMAD4—may predispose to both PAH and HHT(−characteristic) disease features. The PAVM in our patient spread diffusely inside the lower lobe of the left lung, and coil embolization was considered difficult. Therefore, after feasibility assessment by performing a balloon occlusion test during cardiac catheterization, left lower lobectomy was performed. The patient's dyspnea recovered well postoperatively, and two years later an increase in left lung volume was observed and disease symptoms had not recurred. Thus, if PAVM spreads diffusely in a certain lung area, surgical treatment can be a viable option.

Learning objective

SMAD9 gene mutations have been linked to pulmonary arterial hypertension (PAH). However, their associations with hereditary hemorrhagic telangiectasia (HHT) or pulmonary arteriovenous malformation (PAVM), which usually is HHT-associated, have not been reported previously. Our PAVM patient carrying a SMAD9 variant suggests that mutations in this gene, like in others participating in TGF-β family signaling pathways (like ENG, ACVRL1, and SMAD4), predispose to both PAH and HHT(−characteristic) disease features. Diffuse PAVM confined to a lung area may be treated by lobectomy.
一个新的SMAD9无义变异在一个11岁的日本患者弥漫性肺动静脉畸形:一个病例报告
大多数肺动静脉畸形(PAVM)与遗传性出血性毛细血管扩张(HHT)有关。HHT通常由基因ENG、ACVRL1或SMAD4的功能缺失基因突变引起,这些基因都参与转化生长因子β (TGF-β)家族信号通路。我们描述一个11岁的日本女孩与PAVM的情况下,没有已知的HHT家族史或类似的疾病。她被发现携带一种新的无意义的SMAD9变异(SMAD9-p)。T267*),我们推测这与她的疾病有关,因为SMAD9也参与TGF-β家族信号通路。SMAD9突变与肺动脉高压(PAH)有关,因此,SMAD9突变(如ENG、ACVRL1和smad4)可能易患PAH和HHT(−特征性)疾病特征。本例患者的PAVM在左肺下叶内弥漫性扩散,线圈栓塞被认为是困难的。因此,在心导管插管期间进行球囊闭塞试验评估可行性后,进行左下叶切除术。患者术后呼吸困难恢复良好,两年后观察到左肺体积增加,疾病症状未复发。因此,如果PAVM在某一肺区域弥漫性扩散,手术治疗是可行的选择。研究目的mad9基因突变与肺动脉高压(PAH)有关。然而,它们与遗传性出血性毛细血管扩张(HHT)或肺动静脉畸形(PAVM)的关联,通常与HHT相关,以前未见报道。我们的携带SMAD9变异的PAVM患者表明,该基因的突变与其他参与TGF-β家族信号通路的基因(如ENG、ACVRL1和SMAD4)一样,易患PAH和HHT(−特征性)疾病特征。局限于肺区域的弥漫性肺泡炎可通过肺叶切除术治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiology Cases
Journal of Cardiology Cases Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.90
自引率
0.00%
发文量
177
审稿时长
59 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信